Cumberland Pharmaceuticals Inc (NASDAQ: CPIX) stock closed at $6.05 on 3/4/25 after a major increase of 17.7%. However, trading volume in this advance was exceptionally low at 19% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 20.0% during the last week.
Current PriceTarget Research Rating
Cumberland Pharmaceuticals has a current Value Trend Rating of C (Neutral). With this rating, PTR's two proprietary measures of a stock's current attractiveness are providing very contradictory signals. Cumberland Pharmaceuticals has a very low Appreciation Score of 9 but a very high Power Rating of 89, with the Neutral Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.